SCHEMBL25492272

SCHEMBL25492272

CNC(=O)CCCSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23640086 0.93 LMNA (0.54) —
SCHEMBL7904847 0.85 — —
SCHEMBL17833860 0.82 LMNA (0.58) —
SCHEMBL14455151 0.79 LMNA (0.60) —
SCHEMBL4974867 0.79 — —
SCHEMBL5909180 0.79 LMNA (0.57) —
SCHEMBL7753090 0.79 LMNA (0.57) —
SCHEMBL9883923 0.77 TSHR (0.59) —
SCHEMBL12333287 0.76 HDAC3 (0.55) —
SCHEMBL5909483 0.76 HDAC3 (0.55) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023088236-A1 BICYCLIC PEPTIDE LIGAND OF MT1-MMP AND CONJUGATE THEREOF 海思科医药集团股份有限公司 2023-05-25 — — WO disclosed
US-20230149560-A1 LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2023-05-18 — — US disclosed
US-20230149560-A1 LIPID COMPOSITIONS FOR DELIVERY OF STING AGONIST COMPOUNDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2023-05-18 — — US disclosed
Send feedback